Lataa...
Molecular markers of prognosis and therapeutic targets in metastatic colorectal cancer
Metastatic disease ultimately occurs in approximately 50–70% of patients presenting with colorectal cancer. In patients with advanced disease, there is significant variability in individual patient outcomes. To improve understanding of tumor behavior, markers such as KRAS and BRAF mutation status ar...
Tallennettuna:
| Julkaisussa: | Surg Oncol |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5152574/ https://ncbi.nlm.nih.gov/pubmed/27566022 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.suronc.2016.05.018 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|